Literature DB >> 18637512

Control of apoptosis by human cytomegalovirus.

A L McCormick1.   

Abstract

Caspase-dependent apoptosis has an important role in controlling viruses, and as a result, viruses often encode proteins that target this pathway. Caspase-dependent apoptosis can be activated from within the infected cell as an intrinsic response to replication-associated stresses or through death-inducing signals produced extrinsically by immune cells. Cytomegaloviruses (CMVs) encode a mitochondria-localized inhibitor of apoptosis, vMIA, and a viral inhibitor of caspase activation, vICA, the functional homologs of Bcl-2 related and c-FLIP proteins, respectively. Evidence from viral mutants deleting either vMIA or vICA suggests that each is necessary and sufficient to promote survival of infected cells undergoing caspase-dependent apoptosis. Additional proteins, including pUL38, IE1(491a), and IE2(579aa), can prevent apoptosis induced by various stimuli, while viruses with deletions of UL38, M45, or m41 undergo apoptosis. The viral RNA, beta2.7, binds mitochondrial respiratory complex I, maintains ATP production late in infection, and prevents death induced by a mitochondrial poison. Thus, CMV alters cell intrinsic defenses employing apoptosis, and multiple viral gene products together control death-inducing stimuli to promote survival.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18637512     DOI: 10.1007/978-3-540-77349-8_16

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  33 in total

Review 1.  Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything.

Authors:  A Loewendorf; C A Benedict
Journal:  J Intern Med       Date:  2010-05       Impact factor: 8.989

Review 2.  Congenital cytomegalovirus infection: molecular mechanisms mediating viral pathogenesis.

Authors:  Mark R Schleiss
Journal:  Infect Disord Drug Targets       Date:  2011-10

3.  Human cytomegalovirus activation of ERK and myeloid cell leukemia-1 protein correlates with survival of latently infected cells.

Authors:  Matthew B Reeves; Abagail Breidenstein; Teresa Compton
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-27       Impact factor: 11.205

4.  Human cytomegalovirus pUL37x1-induced calcium flux activates PKCα, inducing altered cell shape and accumulation of cytoplasmic vesicles.

Authors:  Ronit Sharon-Friling; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-10       Impact factor: 11.205

5.  The human cytomegalovirus UL36 gene controls caspase-dependent and -independent cell death programs activated by infection of monocytes differentiating to macrophages.

Authors:  A Louise McCormick; Linda Roback; Devon Livingston-Rosanoff; Courtney St Clair
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

6.  Cytomegalovirus: pathogen, paradigm, and puzzle.

Authors:  Michael Boeckh; Adam P Geballe
Journal:  J Clin Invest       Date:  2011-05       Impact factor: 14.808

7.  Human cytomegalovirus induces caspase-dependent apoptosis of megakaryocytic CHRF-288-11 cells by activating the JNK pathway.

Authors:  Juan Dou; Xiaofeng Li; Yun Cai; Hong Chen; Shunye Zhu; Qingwen Wang; Xiaobing Zou; Yuping Mei; Qian Yang; Wenming Li; Yifan Han
Journal:  Int J Hematol       Date:  2010-04-08       Impact factor: 2.490

8.  The US27 gene product of human cytomegalovirus enhances signaling of host chemokine receptor CXCR4.

Authors:  Kathleen L Arnolds; Angela P Lares; Juliet V Spencer
Journal:  Virology       Date:  2013-03-13       Impact factor: 3.616

9.  Multiplicity-dependent activation of a serine protease-dependent cytomegalovirus-associated programmed cell death pathway.

Authors:  A Louise McCormick; Linda Roback; Grace Wynn; Edward S Mocarski
Journal:  Virology       Date:  2012-11-14       Impact factor: 3.616

Review 10.  Viral modulation of programmed necrosis.

Authors:  William J Kaiser; Jason W Upton; Edward S Mocarski
Journal:  Curr Opin Virol       Date:  2013-06-15       Impact factor: 7.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.